These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4144343)

  • 1. An abnormality of the alternate pathway of complement activation in sickle-cell disease.
    Johnston RB; Newman SL; Struth AG
    N Engl J Med; 1973 Apr; 288(16):803-8. PubMed ID: 4144343
    [No Abstract]   [Full Text] [Related]  

  • 2. Sickle-cell disease and the properdin system.
    Rosen FS
    N Engl J Med; 1973 Apr; 288(16):845-6. PubMed ID: 4144345
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased susceptibility to infection in sickle cell disease: defects of opsonization and of splenic function.
    Johnston RB; Newman SL; Struth AG
    Birth Defects Orig Artic Ser; 1975; 11(1):322-7. PubMed ID: 238677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
    Winkelstein JA; Shin HS; Wood WB
    J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunodeficiency in sickle-cell anemia.
    Ringelhann B
    N Engl J Med; 1973 Aug; 289(6):326-7. PubMed ID: 4718046
    [No Abstract]   [Full Text] [Related]  

  • 6. Opsonic activity in human serum deficient in C2.
    Johnson FR; Agnello V; Williams RC
    J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.
    Winkelstein JA; Drachman RH
    N Engl J Med; 1968 Aug; 279(9):459-66. PubMed ID: 4385710
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monocyte function in patients with sickle-cell anemia].
    Dorlhiac P; Lorenzi TF; Genter G; Jamra M
    Sangre (Barc); 1985; 30(3):284-91. PubMed ID: 2930905
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of complement assays.
    Alper CA; Rosen FS
    Adv Intern Med; 1975; 20():61-88. PubMed ID: 46689
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: studies on selected complement components and immunoglobulins.
    Bjornson AB; Gaston MH; Zellner CL
    J Pediatr; 1977 Sep; 91(3):371-8. PubMed ID: 19568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative pathway of complement in sickle cell disease.
    Strauss RG; Asbrock T; Forristal J; West CD
    Pediatr Res; 1977 Apr; 11(4):285-9. PubMed ID: 846782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral components of host defense in sickle cell disease during painful crisis and asymptomatic periods.
    Bjornson AB; Lobel JS; Lampkin BC
    J Pediatr; 1980 Feb; 96(2):259-62. PubMed ID: 7351591
    [No Abstract]   [Full Text] [Related]  

  • 13. Opsonins: their function, identity, and clinical significance.
    Winkelstein JA
    J Pediatr; 1973 May; 82(5):747-53. PubMed ID: 4144636
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe pneumococcal infections and immunologic deficiency in children].
    Reinert P; Bernaudin F; Lassale C; Lemerle S
    Bull Eur Physiopathol Respir; 1983; 19(2):205-8. PubMed ID: 6871499
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of complement].
    Wellek B; Opferkuch W
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2356-61. PubMed ID: 4271713
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infection and immunity in sickle cell disease].
    Falcão RP; Donadi EA
    AMB Rev Assoc Med Bras; 1989; 35(2):70-4. PubMed ID: 2695986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat labile opsonin system to pneumococcus.
    Shin HS; Smith MR; Winkelstein J; Nicholson A
    Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.